Taneo, Jonalyn .
HRN: 24-96-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2024
CEFUROXIME 1.5GM (VIAL)
04/28/2024
05/01/2024
IV
1.5gm
Q8
Sp Cs
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes